Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ascendis Pharma A/S

163.24
-2.8100-1.69%
Post-market: 165.482.24+1.37%16:26 EDT
Volume:228.82K
Turnover:37.44M
Market Cap:9.77B
PE:-24.14
High:165.74
Open:164.72
Low:162.71
Close:166.05
Loading ...
Feb 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 12, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 08, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 07, 2024

Annual Report

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Feb 02, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Dec 08, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 06, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 28, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 27, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 21, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 19, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities